REFERENCES

1. Kingsnorth A, LeBlanc K. Hernias: inguinal and incisional. Lancet 2003;362:1561-71.

2. Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, et al. Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet 2015;386:1254-60.

3. Jairam AP, Timmermans L, Eker HH, Pierik REGJM, van Klaveren D, et al. Prevention of incisional hernia with prophylactic onlay and sublay mesh reinforcement versus primary suture only in midline laparotomies (PRIMA): 2-year follow-up of a multicentre, double-blind, randomised controlled trial. Lancet 2017;390:567-76.

4. Weissler JM, Lanni MA, Tecce MG, Carney MJ, Shubinets V, et al. Chemical component separation: a systematic review and meta-analysis of botulinum toxin for management of ventral hernia. J Plast Surg Hand Surg 2017;51:366-74.

5. Deerenberg EB, Timmermans L, Hogerzeil DP, Slieker JC, Eilers PH, et al. A systematic review of the surgical treatment of large incisional hernia. Hernia 2015;19:89-101.

6. Luijendijk RW, Hop WC, van den Tol MP, de Lange DC, Braaksma MM, et al. A comparison of suture repair with mesh repair for incisional hernia. N Engl J Med 2000;343:392-8.

7. Flum DR, Horvath K, Koepsell T. Have outcomes of incisional hernia repair improved with time? A population-based analysis. Ann Surg 2003;237:129-35.

8. Heniford BT, Park A, Ramshaw BJ, Voeller G. Laparoscopic repair of ventral hernias: nine years’ experience with 850 consecutive hernias. Ann Surg 2003;238:391-9.

9. Blair LJ, Ross SW, Huntington CR, Watkins JD, Prasad T, et al. Computed tomographic measurements predict component separation in ventral hernia repair. J Surg Res 2015;199:420-7.

10. Mayagoitia JC, Suárez D, Arenas JC, Díaz de León V. Preoperative progressive pneumoperitoneum in patients with abdominal-wall hernias. Hernia 2006;10:213-7.

11. Wooten KE, Ozturk CN, Ozturk C, Laub P, Aronoff N, et al. Role of tissue expansion in abdominal wall reconstruction: a systematic evidence-based review. J Plast Reconstr Aesthet Surg 2017;70:741-51.

12. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-94.

13. Cakmak M, Caglayan F, Somuncu S, Leventoglu A, Ulusoy S, et al. Effect of paralysis of the abdominal wall muscles by botulinum A toxin to intraabdominal pressure: an experimental study. J Pediatr Surg 2006;41:821-5.

14. Ibarra-Hurtado TR, Nuño-Guzmán CM, Echeagaray-Herrera JE, Robles-Vélez E, De Jesús González-Jaime J. Use of botulinum toxin type A before abdominal wall hernia reconstruction. World J Surg 2009;33:2553-6.

15. Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallet M, Mayer NH. Botulinum Toxin: Therapeutic Clinical Practice and Science. Philadelphia: Saunders Elsevier; 2009. p. 512.

16. Ibarra-Hurtado TR, Nuño-Guzmán CM, Miranda-Díaz AG, Troyo-Sanromán R, Navarro-Ibarra R, et al. Effect of botulinum toxin type A in lateral abdominal wall muscles thickness and length of patients with midline incisional hernia secondary to open abdomen management. Hernia 2014;18:647-52.

17. Zendejas B, Khasawneh MA, Srvantstyan B, Jenkins DH, Schiller HJ, et al. Outcomes of chemical component paralysis using botulinum toxin for incisional hernia repairs. World J Surg 2013;37:2830-7.

18. Farooque F, Jacombs AS, Roussos E, Read JW, Dardano AN, et al. Preoperative abdominal muscle elongation with botulinum toxin A for complex incisional ventral hernia repair. ANZ J Surg 2016;86:79-83.

19. Rodriguez-Acevedo O, Elstner KE, Jacombs ASW, Read JW, Martins RT, et al. Preoperative botulinum toxin A enabling defect closure and laparoscopic repair of complex ventral hernia. Surg Endosc 2018;32:831-9.

20. Bueno-Lledó J, Torregrosa A, Jiménez R, Pastor PG. Preoperative combination of progressive pneumoperitoneum and botulinum toxin type A in patients with loss of domain hernia. Surg Endosc 2018;32:3599-608.

21. Bueno-Lledó J, Torregrosa-Gallud A. Preoperative botulinum toxin and progressive pneumoperitoneum are useful in the treatment of large incisional hernias. Am Surg 2019;85:e189-92.

22. Elstner KE, Read JW, Saunders J, Cosman PH, Rodriguez-Acevedo O, et al. Selective muscle botulinum toxin A component paralysis in complex ventral hernia repair. Hernia 2020;24:287-93.

23. Nielsen M, Bjerg J, Dorfelt A, Jørgensen LN, Jensen KK. Short-term safety of preoperative administration of botulinum toxin A for the treatment of large ventral hernia with loss of domain. Hernia 2020;24:295-9.

24. Chan DL, Ravindran P, Fan HS, Elstner KE, Jacombs ASW, et al. Minimally invasive Venetian blinds ventral hernia repair with botulinum toxin chemical component separation. ANZ J Surg 2020;90:67-71.

25. Scaglione F. Conversion ratio between botox®, dysport®, and xeomin® in clinical practice. Toxins (Basel) 2016;8.

26. Booth JH, Garvey PB, Baumann DP, Selber JC, Nguyen AT, et al. Primary fascial closure with mesh reinforcement is superior to bridged mesh repair for abdominal wall reconstruction. J Am Coll Surg 2013;217:999-1009.

27. Cobb WS, Burns JM, Kercher KW, Matthews BD, James Norton H, et al. Normal intraabdominal pressure in healthy adults. J Surg Res 2005;129:231-5.

28. Ramirez OM, Ruas E, Dellon AL. “Components separation” method for closure of abdominal-wall defects: an anatomic and clinical study. Plast Reconstr Surg 1990;86:519-26.

29. Novitsky YW, Elliott HL, Orenstein SB, Rosen MJ. Transversus abdominis muscle release: a novel approach to posterior component separation during complex abdominal wall reconstruction. Am J Surg 2012;204:709-16.

30. Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord 1997;12:89-94.

31. Tomazini Martins R, Elstner KE, Skulina C, Rodriguez-Acevedo O, Read JW, et al. Limitations of electromyography in the assessment of abdominal wall muscle contractility following botulinum toxin a injection. Front Surg 2019;6:16.

32. Yiannakopoulou E. Serious and long-term adverse events associated with the therapeutic and cosmetic use of botulinum toxin. Pharmacology 2015;95:65-9.

33. Chertow DS, Tan ET, Maslanka SE, Schulte J, Bresnitz EA, et al. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation. JAMA 2006;296:2476-9.

34. Scott AB, Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 1988;3:333-5.

35. Herrero BA, Ecklund AE, Spencer Streett C, Ford DF, King JK. Experimental botulism in monkeys-A clinical pathological study. Exp Mol Pathol 1967;6:84-95.

Plastic and Aesthetic Research
ISSN 2349-6150 (Online)   2347-9264 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/